- Home
- PHAT vs GDEN Comparison
PHAT vs GDEN Comparison
Compare PHAT & GDEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- GDEN
- Stock Information
- Founded
- PHAT 2018
- GDEN 1998
- Country
- PHAT United States
- GDEN United States
- Employees
- PHAT N/A
- GDEN N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- GDEN Services-Misc. Amusement & Recreation
- Sector
- PHAT Health Care
- GDEN Consumer Discretionary
- Exchange
- PHAT Nasdaq
- GDEN Nasdaq
- Market Cap
- PHAT 640.9M
- GDEN 727.9M
- IPO Year
- PHAT 2019
- GDEN 1999
- Fundamental
- Price
- PHAT $8.35
- GDEN $27.61
- Analyst Decision
- PHAT Strong Buy
- GDEN Buy
- Analyst Count
- PHAT 5
- GDEN 6
- Target Price
- PHAT $16.40
- GDEN $36.50
- AVG Volume (30 Days)
- PHAT 937.1K
- GDEN 196.6K
- Earning Date
- PHAT 08-07-2025
- GDEN 08-07-2025
- Dividend Yield
- PHAT N/A
- GDEN 3.62%
- EPS Growth
- PHAT N/A
- GDEN N/A
- EPS
- PHAT N/A
- GDEN 0.39
- Revenue
- PHAT $81,859,000.00
- GDEN $653,614,000.00
- Revenue This Year
- PHAT $195.03
- GDEN $0.92
- Revenue Next Year
- PHAT $106.77
- GDEN $2.31
- P/E Ratio
- PHAT N/A
- GDEN $71.08
- Revenue Growth
- PHAT 3055.70
- GDEN N/A
- 52 Week Low
- PHAT $2.21
- GDEN $22.66
- 52 Week High
- PHAT $19.71
- GDEN $35.49
- Technical
- Relative Strength Index (RSI)
- PHAT 47.45
- GDEN 38.36
- Support Level
- PHAT $7.61
- GDEN $28.35
- Resistance Level
- PHAT $9.23
- GDEN $32.74
- Average True Range (ATR)
- PHAT 0.66
- GDEN 0.99
- MACD
- PHAT -0.08
- GDEN -0.29
- Stochastic Oscillator
- PHAT 30.64
- GDEN 4.17
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About GDEN Golden Entertainment Inc.
Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.